Preprint · CC-BY
via OpenAlex
Performance of cellular senescence measure, p16, and DNA methylation clocks in a clinically relevant model of age acceleration
Mina S. Sedrak, Anne K. Knecht, Susan L. Strum, Can‐Lan Sun, Yuan Chun Ding, Jingran Ji, Thomas A. White, Kirsten A. Nyrop, Nathan K. LeBrasseur, Susan L. Neuhausen, Natalia Mitin, Hyman Bernard Muss
medRxiv · 2023 · ▲ 2 citations
Abstract
ABSTRACT Cellular senescence(definition) and DNA methylation are primary aging mechanisms emerging as a potential means of monitoring human aging and evaluating interventions thought to either accelerate or slow an individual’s aging trajectory. However, it is largely unknown whether cellular senescence and signatures of methylation of the specific CpG islands that comprise various epigenetic clocks correlate in humans. We have measured the cellular senescence biomarker, p16 and the five most used epigenetic aging clocks in 251 patients with breast cancer, 49 age-matched non-cancer controls, and 48 patients undergoing cytotoxic chemotherapy treatment. Chemotherapy, a known clinically-relevant inducer of aging, increased expression of p16 but not levels of the most common epigenetic clocks (DNAm-Horvath, PhenoAge, GrimAge, mPoA), with the exception of DNAm-Hannum. Chemotherapy-induced changes in p16 were associated with increased levels of a subset of SASPs, PARC, TNFRII, ICAM1, and TNFa. Cross-sectionally, there was weak to no correlation between p16 expression and epigenetic clocks in cancer patients or non-cancer controls. GrimAge and PhenoAge were the most correlated with p16 (r<0.3), with no correlation between p16 and the pace of aging epigenetic clock(definition). Together, these data show that there is a general discordance between measures of cellular senescence and epigenetic clocks with the senescence marker p16 but not epigenetic clocks of aging responding to a clinically relevant inducer of human aging, cytotoxic chemotherapy.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/2023.05.06.23289535
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Sedrak, M.S., Knecht, A.K., Strum, S.L., Sun, C., Ding, Y.C., Ji, J., White, T.A., Nyrop, K.A., LeBrasseur, N.K., Neuhausen, S.L., Mitin, N., & Muss, H.B. (2023). Performance of cellular senescence measure, p16, and DNA methylation clocks in a clinically relevant model of age acceleration. <em>medRxiv</em>. https://doi.org/10.1101/2023.05.06.23289535
Vancouver
Sedrak MS, Knecht AK, Strum SL, Sun C, Ding YC, Ji J, et al. Performance of cellular senescence measure, p16, and DNA methylation clocks in a clinically relevant model of age acceleration. medRxiv. 2023. doi:10.1101/2023.05.06.23289535.
BibTeX
@unpublished{mina2023Perfor,
title = {Performance of cellular senescence measure, p16, and DNA methylation clocks in a clinically relevant model of age acceleration},
author = {Mina S. Sedrak and Anne K. Knecht and Susan L. Strum and Can‐Lan Sun and Yuan Chun Ding and Jingran Ji and Thomas A. White and Kirsten A. Nyrop and Nathan K. LeBrasseur and Susan L. Neuhausen and Natalia Mitin and Hyman Bernard Muss},
journal = {medRxiv},
year = {2023},
doi = {10.1101/2023.05.06.23289535},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
GeroScience 2026
Open access · CC-BY
p16INK4a and DNA methylation clocks in women treated with chemotherapy for early breast cancer
2020
Preprint · CC-BY
Novel Epigenetic Clock for Fetal Brain Development Predicts Fetal Epigenetic Age for iPSCs and iPSC-Derived Neurons.
Molecular Brain 2021
Open access · CC-BY
Novel epigenetic clock for fetal brain development predicts prenatal age for cellular stem cell models and derived neurons
Aging cell 2026
Open access · OA
DNA Methylation Signatures of Cellular Senescence Are Not Reversed by Senolytic Treatment.
Clinical Epigenetics 2024
Open access · CC-BY
Influence of physical activity on the epigenetic clock: evidence from a Japanese cross-sectional study
medRxiv 2026
Preprint · CC-BY